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Background and aim: Liver regeneration after severe liver damage depends in part on proliferation
and differentiation of hepatic progenitor cells (HPCs). Under these conditions they must be able to
withstand the toxic milieu of the damaged liver. ATP binding cassette (ABC) transporters are cytopro-
tective efflux pumps that may contribute to the preservation of these cells. The aim of this study was to
determine the ABC transporter phenotype of HPCs.
Methods: HPC activation was studied in rats treated with 2- acetylaminofluorene (2-AAF) followed by
partial hepatectomy (PHx). ABC transporter gene expression was determined by real time detection
reverse transcription-polymerase chain reaction in isolated HPCs, hepatocytes, cholangiocytes, and
cultured progenitor cell-like RLF φ 13 cells and by immunohistochemistry of total liver samples. ABC
transporter efflux activity was studied in RLF φ 13 cells by flow cytometry.
Results: 2-AAF/PHx treated animals showed increased hepatic mRNA levels of the genes encoding
multidrug resistance proteins Mdr1b, Mrp1, and Mrp3. Immunohistochemistry demonstrated
expression of Mrp1 and Mrp3 proteins in periportal progenitor cells and of the Mdr1b protein in peri-
portal hepatocytes. Freshly isolated Thy-1 positive cells and cultured RLF φ 13 progenitor cells highly
expressed Mrp1 and Mrp3 mRNA while the hepatocyte specific transporters Mdr2, Bsep, Mrp2, and
Mrp6 were only minimally expressed. Blocking Mrp activity by MK-571 resulted in accumulation of the
Mrp specific substrate carboxyfluorescein in RLF φ 13 cells.
Conclusion: HPCs express high levels of active Mrp1 and Mrp3. These may have a cytoprotective role
in conditions of severe hepatotoxicity.
Liver regeneration occurs after loss of liver tissue due to toxicinjury or partial hepatectomy (PHx) and is predominantlyaccomplished by replication of hepatocytes. Under condi-
tions in which hepatocytes cannot proliferate, liver damage
results in activation of the hepatic progenitor cell (HPC)
compartment.1 In humans, this occurs during severe liver
injury when a significant number of hepatocytes are lost. In
rats, HPC proliferation can be achieved by treatment with
2-acetylaminofluorene (2-AAF) in combination with PHx or
carbon tetrachloride (CCl4) administration. Treatment with
2-AAF followed by PHx causes a block in hepatocyte prolifera-
tion at the G1/S restriction point due to decreased expression
of cyclin E and increased hepatocytic expression of p53 and
p21.2 HPCs, located in the canals of Hering,3 escape from the
2-AAF induced blockade and proliferate in the 2-AAF/PHx
model. Their proliferation reaches a maximal level 9–11 days
after hepatic injury.4 5 HPCs resemble fetal hepatic cells as they
express fetal markers such as α-fetoprotein and Thy-1 at high
levels and are considered to be the bipotential precursors of
hepatocytes and cholangiocytes.1 4 6
HPCs are only activated after severe liver damage and are
thought to represent a back up mechanism for hepatic regen-
eration. We hypothesise that, in view of their critical role in
hepatic repair after excessive damage, HPCs should be able to
protect themselves against toxic metabolites and xenobiotics,
concentrations of which increase during reduced liver
function. One mechanism of cellular protection is expression
of efflux pumps that belong to the ATP binding cassette (ABC)
superfamily of membrane transporters.7
The ABC transporter family consists of approximately 48
members that have been divided into seven subclasses (A–G)
based on their amino acid sequence homologies. Members of
the Abcb (multidrug resistance proteins) subfamily that are
expressed in the liver include efflux pumps for hydrophobic
compounds and chemotherapeutic agents (Mdr1a/b in
rodents, gene symbol Abcb1a/b,MDR1 in humans),8 9 a flippase
that translocates phosphatidylcholine across the membrane
(Mdr2, Abcb4, MDR3 in humans),10 and the export pump for
bile salts Bsep (Abcb11).11 These transporters are all located in
the canalicular membrane of hepatocytes, transporting their
substrates into bile (reviewed in Hooiveld and colleagues12).
The Abcc (multidrug resistance associated protein) sub-
family consists of 12 members, of which at least four (Mrp1,
Mrp2, Mrp3, and Mrp6) are expressed in normal liver
(reviewed by Borst and Oude Elferink7). Mrp2 (Abcc2) is
present in the canalicular membrane of hepatocytes. Mrp1
(Abcc1) is located in the basolateral membrane but is
expressed only at low levels in normal liver. Mrp1 expression
is induced in proliferating hepatocytes.13 Mrp1 and Mrp2 have
a similar substrate specificity and transport glutathione
S-conjugates, cysteinyl-leukotrienes, bilirubin glucuronides,
oestrogen glucuronides, and glutathione disulphide.14 Hepatic
expression of Mrp3, Mrp4, and Mrp6 has been reported
recently.15 In normal liver, Mrp3 (Abcc3) is expressed in the
basolateral membrane of pericentrally localised hepatocytes
and in cholangiocytes.16 17 Mrp3 can transport mono- and
bivalent bile salts as well as glucuronide conjugates.18 19 Its
expression is increased during cholestasis and in conditions of
conjugated or unconjugated hyperbilirubinaemia (Gunn rats
andMrp2 deficient mutant rats).16 20 Mrp4 (Abcc4) is an export
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pump for organic anions but is also capable of transporting
cyclic nucleotides and nucleotide analogues.21 22 In normal
liver, Mrp4 is expressed at low levels.15 However, enhanced
hepatocellular concentrations of bile salts increase Mrp4
expression in liver.23 Mrp6 (Abcc6) is expressed at high levels in
normal liver, predominantly in the (baso)lateral membrane of
hepatocytes.24 Its substrate specificity is presently less well
defined.
A number of these transporters have been linked to cellular
protection. Mdr1b functions as an efflux pump for toxins and
may also have an antiapoptotic role.25 26 Mrp1 is a transporter
of leukotriene C4 and the glutathione conjugate of prosta-
glandin A2, factors involved in inflammation and cell cycle
arrest. Moreover, Mrp1 mediated transport of glutathione
disulphide and glutathione conjugated 4-hydroxynonenal
suggests that Mrp1 functions as part of the cellular defence
system against oxidative stress (reviewed by Renes and
colleagues14). Mrp3 may have an important role in protecting
cells from excessive amounts of endogenous bile salts by
extruding these into blood.18 19
Two additional members of the ABC family that may be rel-
evant for progenitor cell survival are Abca1 and Bcrp (Abcg2).
Abca1 is highly expressed in fetal liver where its expression
correlates with apoptotic areas.27 In adult life, Abca1 is ubiqui-
tously expressed in various tissues and organs.28 It is essential
for HDL formation29 but its specific function in adult liver is
currently unknown. Bcrp is expressed at relatively low levels
in the apical membrane of hepatocytes.30 Expression of Bcrp
can, in common with Mdr1a/b and Mrp1, cause multidrug
resistance.31 Bcrp has been demonstrated to have a cytoprotec-
tive role in a subgroup of haematopoietic stem cells.32
The expression profile of ABC transporters in the HPC com-
partment is not known. As these cells represent a potential
proliferative reservoir of a severely damaged liver,we speculate
that these cells must be well protected. We therefore studied
ABC transporter expression in HPCs.
MATERIALS AND METHODS
Animals
Specified pathogen free male Wistar and Fisher 344 rats (130–
170 g) were purchased from Harlan-CPB, Zeist, the Nether-
lands, and were kept under routine laboratory conditions with
a 12 hour light-dark cycle at the Central Animal Laboratory of
the University of Groningen. Rats received standard labora-
tory chow and had free access to food and water. This study
was approved by the Local Committee for Care and Use of
Laboratory Animals.
Animal experiments
2-AAF/PHx induced oval cell activation in rats
Seven days before PHx, 2-AAF pellets (70 mg/pellet over a 28
day release, 2.5 mg/day; Innovative Research Inc., Sarasota,
Florida, USA) or placebo pellets were placed subcutaneously
in Wistar rats. PHx was performed according to the technique
of Higgins and Anderson, removing two thirds of the liver.33
Sham operated animals underwent the same treatment
protocol, including manipulation of the intestine and liver, but
without hepatectomy. All surgery was performed under
halothane anaesthesia. Nine days after surgery, livers were
perfused with phosphate buffered saline (PBS) via the portal
vein, excised, cut into small pieces, and snap frozen in liquid
nitrogen for RNA isolation or frozen in cold 2-methyl-butane
for immunohistochemistry. Tissue was stored at −80°C prior to
use.
PHx induced hepatocyte proliferation in rats
To determine transporter expression in proliferating hepato-
cytes, Wistar rats were either sham operated or underwent
PHx.33 At 24 hours post PHx, hepatocytes were isolated using
a two step collagenase perfusion technique, as described
previously.34 Cell fractions were frozen in liquid nitrogen prior
to RNA isolation.
Isolation of hepatic cell fractions
Specific hepatic cell fractions were isolated from male Fischer
344 rats. Cholangiocytes were isolated as described by Ishii
and colleagues35 from five rats to obtain sufficient amounts of
RNA. Oval cells were isolated from rats 12 days after
2-AAF/CCl4 treatment, as described by Petersen and
colleagues.4 Hepatocytes were isolated according to Moshage
and colleagues.34
Cell culture
The progenitor cell-like cell line RLF φ 13 was a kind gift from
Dr SS Thorgeirsson (Laboratory of Experimental Carcinogen-
esis, Division of Basic Sciences, National Cancer Institute,
Bethesda, USA) and has been described previously.36 Cells
were maintained in Ham’s F12 (Invitrogen Life Technologies,
Paisley, UK) supplemented with 10% fetal calf serum and
50 µg/ml gentamycin (Invitrogen Life Technologies). Cells
were grown to 90–95% confluence prior to experiments in a
humidified incubator at 37°C/5% CO2.
Antibodies
The mouse monoclonal antibody C219 (Dako, Glostrup,
Denmark) was used for detection of all P-glycoproteins. The
goat polyclonal anti-MRP1 antibody SC-7774 (Santa Cruz
Biotechnology, Santa Cruz, California, USA) was used for
detection of Mrp1. The rabbit polyclonal anti-rat Mrp3
antibody was a kind gift from Dr H Suzuki (University of
Tokyo, Tokyo, Japan).37 The OV-6 antibody was a kind gift from
Dr S Sell (Albany Medical College, Albany, New York, USA).38
Immunohistochemistry
For immunohistological studies, 4 µm sections were cut from
frozen liver tissue. After drying, sections were fixed in acetone
for 10 minutes at room temperature and washed in PBS,
immediately before use. Primary antibodies were incubated
for 30 minutes at room temperature. For monoclonal antibod-
ies, a peroxidase staining method was used with secondary
antibodies, preabsorbed with rat serum (Sigma, St Louis, Mis-
souri, USA). For the rabbit polyclonal antibodies, the
rabbit-EnVision staining method (Dako) was used. For the
goat polyclonal antibody, the secondary step consisted of
swine anti-goat IgG (Dako), followed by goat peroxidase-anti-
peroxidase (Dako). Secondary and tertiary antibodies were
diluted in PBS containing 10% normal rat serum. All incuba-
tion steps were performed for 30minutes at room temperature
and were followed by three washes in three changes of PBS for
five minutes.
For semi quantitative estimations of protein expression, a
series of dilutions of the primary antibodies were used (1/10;
1/30; 1/50; 1/100; 1/200; 1/500; 1/1000) and staining intensities
were determined by microscopy. When staining was at the
limit of detectability and disappeared at a higher dilution, it
was evaluated as “critical staining”. For each liver specimen,
this critical staining was evaluated in each cell compartment
separately. The dilution at which critical staining was observed
is indicative for the relative up- or downregulation of protein
levels in each liver cell compartment.
RNA isolation and quantitative PCR
Total RNA was isolated from tissue or cells using TRIzol (In-
vitrogen Life Technologies) followed by the SV Total RNA iso-
lation system (Promega,Madison,Wisconsin, USA) according
to the manufacturer’s instructions. Reverse transcription (RT)
was performed on 5 µg of total RNA using random primers in
a final volume of 75 µl (Reverse Transcription System;
Promega).
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cDNA levels of the various genes were measured by real
time polymerase chain reaction (PCR) using the ABI PRISM
7700 sequence detector (Applied Biosystems, Foster City, Cali-
fornia, USA). Cycle numbers at which the sample fluorescence
signal increases above a fixed threshold level (CT value) corre-
late inversely with mRNA levels.39 We used 4 µl of a 20-fold
diluted cDNA in each PCR reaction in a final volume of 20 µl,
containing 900 nM of sense and antisense primers, 200 nM of
fluorogenic probe, 5 mM MgCl2, KCl, Tris HCl, 0.2 mM dATP,
dCTP, dGTP, dTTP, and dUTP, and 0.5 U of AmpliTaq DNA
polymerase (qPCR Core Kit; Eurogentech, Seraing, Belgium).
Sequences of the primers and probes used are listed in table 1.
Probes were labelled by a 5′ FAM (6-carboxy-fluorescein)
reporter and a 3′ TAMRA (6-carboxy-tetramethyl-rhodamine)
quencher. The PCR programwas 95°C for 10 minutes, followed
by 40 cycles of 15 seconds at 95°C and one minute at 60°C.
Each sample was analysed in duplicate. For quantification of
mRNA expression, calibration curves were constructed ex-
pressing the log of the input amount as x and CT as y. 18S
expression levels were used as endogenous controls.
Data resulting from the experimental groups are expressed
as mean (SD). Differences between the four experimental
groups in the 2-AAF/PHx experiment were determined by one
way ANOVA analysis, with post hoc comparison by the
Student-Newman-Keuls test (SPSS software). An unpaired
Student’s t test was used to compare the means of the two
groups. A p value <0.05 was considered significant.
Flow cytometric detection of functional efflux
Functional activity of the MRP transporter proteins was dem-
onstrated essentially according to Van der Kolk and
colleagues.40 Cells were exposed to 0.1 µM carboxyfluorescein
diacetate (CFDA) (Sigma) in combination with the Mrp
inhibitor MK571 (kindly provided by Dr Ford-Hutchinson,
Table 1 Sequences of polymerase chain reaction (PCR) primers and probes used
for real time detection PCR analysis
cDNA Primer
Mdr1a
Sense 5′-GCA GGT TGG CTG GAC AGA TT-3′
Antisense 5′-GGA GCG CAA TTC CAT GGA TA-3′
Probe 5′ FAM-CCG CCA GAG TTC CCA GCA GCA TG-TAMRA 3′
Mdr1b
Sense 5′-AAA CAT GGC ACG TAA CCA AAG TT-3′
Antisense 5′-AAA ATG TGG CCC TGT TTA ATG ATT-3′
Probe 5′ FAM-CAC TGT TAA AGG TAA TTT CAT CAA GAC GAG AAG CCT
TC-TAMRA 3′
Mdr2
Sense 5′-AGT TCA CGG GCG CAT CAA-3′
Antisense 5′-AAA AGA CAC TGG TGG CAC GTT-3′
Probe 5′ FAM-CAT CAA GTT CAT TGG TTT CCA CAT CCA GC-TAMRA 3′
Bsep
Sense 5′-CCA AGC TGC CAA GGA TGC TA-3′
Antisense 5′-CCT TCT CCA ACA AGG GTG TCA-3′
Probe 5′ FAM-CAT TAT GGC CCT GCC GCA GCA-TAMRA 3′
Mrp1
Sense 5′-GCC ACT GCC TCA TGC CTA TT-3′
Antisense 5′-GCA AGA CCT GAA GGC AAG ATA CA-3′
Probe 5′ FAM-AGC CAC ATT TAT AGA GCC AAG CCA GAG CC-TAMRA 3′
Mrp2
Sense 5′-GAC GAC GAT GAT GGG CTG AT-3′
Antisense 5′-CTT CTC ATG GCC AAG GAA GCT-3′
Probe 5′ FAM-CCC ACC ATG GAG GAA ATC CCT GAG G-TAMRA 3′
Mrp3
Sense 5′-TCC CAC TTC TCG GAG ACA GTA ACT-3′
Antisense 5′-CTT AGC ATC ACT GAG GAC CTT GAA-3′
Probe 5′ FAM-CAG TGT CAT TCG GGC CTA CGG CC-TAMRA 3′
Mrp4
Sense 5′-TCA GTG TTG GAC AGA GAC AGT TAG TG-3′
Antisense 5′-CTT CTC CCG GAT TTT CTG TTG TAT-3′
Probe 5′ FAM-TCA GTT CTC GGA TCC ACA TTT GCA GTT G-TAMRA 3’
Mrp6
Sense 5′-CTC TCC CAT TGG CTT CTT TGA G-3′
Antisense 5′-GTC CAC ATC CAC TAT GTC CGT CT-3′
Probe 5′ FAM-TCG GGA ACC TGC TGA ACC GTT TTT C-TAMRA 3’
Abca1
Sense 5′-CCC AGA GCA AAA AGC GAC TC-3′
Antisense 5′-GGT CAT CAT CAC TTT GGT CCT TG -3′
Probe 5′ FAM-AGA CTA CTC TGT CTC TCA GAC AAC ACT TGA CCA
AG-TAMRA 3’
Bcrp
Sense 5′-CAG GTA GGC AAT TGT GAG GAA GA-3′
Antisense 5′-AAT CAG GGC ATC GAT CTG TCA-3′
Probe 5′ FAM-CAT GCA AGC CAG GGC CAC ATG A-TAMRA 3’
Thy1
Sense 5′-GCA GAT GTC CCG AGG ACA GA-3′
Antisense 5′-GGC AGT CCA GTC GAA GGT TCT-3′
Probe 5′ FAM-CAG CCT GAC AGC CTG CCT GGT GA-TAMRA 3’
18S
Sense 5′-CGG CTA CCA CAT CCA AGG A-3′
Antisense 5′-CCA ATT ACA GGG CCT CGA AA-3′
Probe 5′ FAM-CGC GCA AAT TAC CCA CTC CCG A-TAMRA 3′
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Merck Sharp, Canada). Carboxyfluorescein (CF) fluorescence
of 5000 cells was measured at a laser excitation wavelength of
488 nm through a 530 nm band pass filter using a FACScalibur
flow cytometer (Becton Dickinson Medical Systems, Sharon,
Massachusetts, USA). The efflux blocking factor of the inhibi-
tor was expressed as median fluorescence intensity in inhibi-
tor treated cells divided by median fluorescence intensity in
untreated cells.
RESULTS
Characteristics of partial hepatectomised rats
Rats were treated with 2-AAF or placebo for seven days before
undergoing PHx or sham operation. Mean body weight of the
rats was 196 (13.1) g when 2-AAF or placebo pellets were
placed and 242 (17.1) g at the time of surgery. There was no
significant difference in body weight between rats receiving
placebo pellets and those receiving 2-AAF containing pellets.
On average, 7.6 (0.7) g of liver were excised during PHx. Ani-
mals undergoing 2- AAF/PHx treatment gained approximately
20 g in weight over the nine days after PHx compared with
approximately 40 g for rats in the placebo/sham, placebo/PHx,
and 2- AAF/sham groups. Liver weights from sham operated
animals were used to calculate the per cent liver weight/body
weight (4.5%). From this, the percentage of liver removed
from the partial hepatectomised rats was estimated to be 71%.
ABC transporter gene expression in total liver samples
during progenitor cell activation
Figure 1 shows hepatic expression of the ABC genes in the
four experimental groups, nine days after PHx or sham opera-
tion. Expression of Mdr1b mRNA was strongly increased in
both groups treated with 2-AAF: 79 (20)-fold in 2-AAF-
treated rats and 120 (53)-fold in 2- AAF/PHx treated rats
(relative to 1.0 (0.6) and 0.3 (0.07) in the placebo/sham and
placebo/PHx groups). In contrast, hepatic mRNA levels of
Mdr2 (2.0-fold), Mrp1 (2.5-fold), Mrp3 (10-fold), and Mrp4
(2.0-fold) were significantly increased only in 2-AAF/HPx
treated rats. mRNA expression levels of Mdr1a, Bsep, Mrp2,
Mrp6, Abca1, and Bcrp1 were comparable for all four groups.
Hepatic progenitor cells contain high levels of Mrp1
and Mrp3
To determine the predominance of HPCs in rats treated with
2-AAF or 2-AAF/PHx, we performed immunohistochemical
stainings using the OV6 antibody. Rats treated with 2-AAF
alone showed mild proliferation of HPCs in their livers (fig
2A). Massive HPC proliferation was observed in livers of
2-AAF/HPx treated rats (fig 2B).
Next, localisation of selected ABC transporters was deter-
mined by immunohistochemistry. Figure 2C shows the clear
canalicular staining pattern of C219, a monoclonal antibody
recognising all P-glycoproteins, in normal rat liver. C219
staining intensity was much more pronounced in livers of
2-AAF and 2-AAF/PHx treated rats and was observed
predominantly in periportal hepatocytes in both groups
(shown for 2-AAF/HPx in fig 2D). Comparison of the staining
patterns of OV6 (fig 2B) and C219 (fig 2D) in serial liver sec-
tions does not reveal any significant colocalisation of these
two markers in HPCs. In an attempt to quantify the relative
increase in Mdr1b protein levels, we performed immunohisto-
chemical experiments with a series of dilutions of the primary
antibody (C219) and determined the upper limit of dilution
Figure 1 mRNA levels of ATP binding cassette (ABC) transporter genes in rat liver after hepatic progenitor cell activation by
2-acetylaminofluorene/partial hepatectomy (2- AAF/PHx) treatment. mRNA expression levels of various ABC transporter genes were
determined by real time detection reverse transcription-polymerase chain reaction, as described in materials and methods. Plac/sham, placebo
pellet followed by sham operation; Plac/PHx: placebo pellet followed by PHx; 2-AAF/sham, 2-AAF pellet followed by sham operation;
2-AAF/PHx, 2-AAF pellet followed by PHx. Data are means (SD), n=3–5 per group. *p<0.05.
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for signal detection (“critical staining” level). Using this
method, the increase in Mdr1b protein level expression for
2-AAF/PHx treated rats was estimated to be over 50-fold com-
pared with controls.
In normal rat liver, expression of Mrp1 is low. We were not
able to detect a specific signal in immunohistochemical
experiments using an antibody against Mrp1 in these livers
Figure 2 Immunohistochemical staining of OV6 (A, B), C219 (C, D), Mrp1 (E, F), and Mrp3 (G, H) in control rat liver (C, E, F),
2-acetylaminofluorene (2-AAF) treated (A) and 2- acetylaminofluorene/partial hepatectomy (2-AAF/PHx) treated rat liver (day 9) (B, D, F, H).
Frozen liver sections were stained with primary antibodies directed against a common epitope in cytokeratin 14 and 19 (OV6, dilution
1/200), all p-glycoproteins (C219, dilution 1/5), Mrp1 (SC-7774, dilution 1/5), or Mrp3 (anti-Mrp3, dilution 1/500). Typical staining
patterns of n=3–5 per group. B, bile duct, P, portal tract, C, central vein; arrows indicate progenitor cell reaction. In rats exposed to 2-AAF,
OV6 stained the bile duct and a number of ductuli (A). In 2-AAF/PHx treated rats, a massively increased number of ductuli were apparent from
intensive OV6 staining (B). In normal liver, C219 weakly stained the canalicular membrane of hepatocytes (C). In 2-AAF/PHx treated rat liver,
C219 staining was increased (D). SC- 7774 did not stain normal liver (E) but significantly stained 2-AAF/PHx treated liver (F). In normal liver,
anti-Mrp3 stained pericentral hepatocytes (G) and bile ducts (insert in (G)). In treated rat liver there was additional staining of oval cells (H).
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(fig 2E). However, in livers of 2-AAF/HPx treated rats, strong
Mrp1 specific staining was observed in HPCs.
In normal rat liver, low levels of Mrp3 are specifically found
in the basolateral membrane of hepatocytes in the centrilobu-
lar zone (fig 2G) and bile ducts (fig 2G insert). In livers of
2-AAF/PHx treated rats, hepatocytes in the entire hepatic aci-
nus contained Mrp3, with higher levels seen in pericentrally
localised hepatocytes (fig 2H). Notably,Mrp3 protein level was
not increased in cholangiocytes. In addition, we observed high
Mrp3 levels in HPCs in the livers of 2-AAF/HPx treated rats.
The Mrp3 signal in HPCs was more intense than the signal in
bile ductular cells.
ABC transporter gene expression in purified hepatic cell
types
To quantify cell type specific ABC transporter gene expression,
we purified hepatocytes, cholangiocytes, and HPCs from
whole liver and subjected these fractions to RT-PCR analysis.
Thy-1 positive cells were isolated from 2-AAF/CCl4 treated rats,
12 days after CCl4 exposure. These cells were compared with
cholangiocytes and hepatocytes isolated from normal rats and
with the progenitor cell-like cell line RLF φ 13. Figure 3 shows
that, as expected, high level expression of Mdr2, Bsep, Mrp2,
Mrp6, and Bcrp, and low level expression of Mdr1b, Mrp1, and
Mrp3 were observed in hepatocytes. In contrast, cholangi-
ocytes contained high levels of Mrp3 and low levels of Mdr1b,
Mdr2, Bsep, Mrp2, Mrp6, and Abca1. Thy-1 positive cells had a
unique ABC phenotype in that they contained high levels of
both Mrp1, Mrp3, and Abca1, a combination not observed in
hepatocytes or cholangiocytes. For the other ABC transporters,
the expression profile was mostly comparable with that of
cholangiocytes. Comparison of transporter expression in
RLF φ 13 cells with that of Thy-1 positive cells showed that
RLF φ 13 cells had similar expression characteristics as Thy1
positive cells. The exception in this respect was Mdr1b mRNA
which was overexpressed in the RLF φ 13 cell line.
Mrp proteins function as active efflux pumps in RLF φ 13
cells
To confirm that expression of Mrp1 and Mrp3 results in
efficient efflux of Mrp substrates from HPCs, we performed
flow cytometric assays using CFDA, which is intracellularly
converted to theMrp substrate CF. Incubation of RLF φ 13 cells
with CFDA resulted in a relative fluorescence of 25.0 (2.4)
units. Performing the same experiment in the presence of the
Mrp inhibitor MK571 (10 and 20 µM) caused retention of CF
of 139.7 (2.2) and 224.9 (20.5) relative fluorescence units,
respectively. Thus MK571 inhibited efflux 5.6- and 9.1- fold. A
representative fluorescence histogram is shown in fig 4.
ABC transporter gene expression in proliferating
hepatocytes
In the experiments described above, the proliferating HPCs
from the 2-AAF/HPx treated rats were compared with hepato-
cytes and cholangiocytes from normal liver. To determine
whether the specific Mrp1, Mrp3, and Abca1 phenotype is
related to the proliferative state of these cells, we also
determined the ABC expression profile of proliferating
hepatocytes. Therefore, rats underwent PHx.Hepatocytes were
isolated 24 hours later. At this time, most hepatocytes are
going through cell division, as determined by BrdU incorpora-
tion (not shown). The ABC transporter profile of these cells is
shown in table 2. Hepatocytes isolated from sham operated
rats were used as controls. As described previously, proliferat-
ing hepatocytes contain high levels ofMdr1b.41 Apart from this
characteristic, no strong differences in ABC transporter
profiles were observed.
Figure 3 mRNA levels of ATP binding cassette (ABC) transporter genes in RLF φ 13 cells, Thy-1 positive cells (Thy-1+), hepatocytes (Hep), and
cholangiocytes (Chol). Relative expression levels of various ABC transporter genes in the different cell fractions were determined by real time
detection reverse transcription-polymerase chain reaction, as described in materials and methods.
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DISCUSSION
In this study,we demonstrated that rat HPCs are characterised
by high level expression of the ABC transporters Mrp1 and
Mrp3. These transporters may protect this important cell
population under toxic conditions in which these cells are
required for repopulation of the liver.
In our in vivo experiments, we induced proliferation of
HPCs by treating rats with 2-AAF followed by PHx.
Concurrently, proliferation of hepatocytes is inhibited and
repopulation of the liver depends on proliferation and
differentiation of hepatic progenitor cells. Nine days after PHx,
mRNA levels of selected ABC transporters in whole liver sam-
ples was determined by real time RT-PCR. Cell specific expres-
sion was analysed by immunohistochemistry. We observed a
particularly strong (up to 120-fold) increase in hepatic Mdr1b
mRNA levels after 2-AAF/PHx treatment compared with
placebo/sham operated rats. A comparable increase (up to
80-fold) of Mdr1b mRNA levels was however also observed in
rats treated with 2-AAF alone where the number of proliferat-
ing HPCs was significantly lower. Immunohistochemistry
showed that Mdr1 protein in livers of 2-AAF/PHx treated rats
was confined to the remaining hepatocytes rather than HPCs.
Apparently, 2-AAF strongly induces expression of this gene.
These results are in agreement with in vitro experiments that
showed that 2-AAF causes an increase in expression of Mdr1b
in cultured rat hepatocytes and rat hepatoma cell lines, as well
as with previous in vivo experiments in rats.42–44 Deng and
colleagues45 have recently elucidated the intracellular signal
transduction pathway involved in upregulation of Mdr1b
mRNA levels by 2-AAF in an in vitro model. They demon-
strated that transcription of Mdr1b is induced by nuclear fac-
tor κB. Activation of nuclear factor κB is the ultimate result of
oxidative stress generated by 2-AAF.45 Moreover, 2-AAF has
been demonstrated to increase p53 expression.2 p53, in turn,
can induce Mdr1b expression.46 The strong C219 staining pat-
tern in rats treated with 2-AAF alone can thus, at least in part,
be explained by direct effects of 2-AAF on hepatocytes. After
2-AAF/PHx treatment, when there is extensive oval cell
activation,Mdr1b protein expression seemed to be confined to
periportal hepatocytes and did not occur in the OV-6 positive
cell compartment or in bile duct epithelial cells. Notably, this
observation contrasts with the human situation. In liver biop-
sies of patients with submassive necrosis, chronic hepatitis C,
or primary biliary cirrhosis, we observed greatly increased
expression of MDR1 not only in the remaining hepatocytes
but also in regenerating ductules that represent putative pro-
genitor cells (Ros et al, in press). The reason for this difference
is not known at present.
Strongly increased expression of Mrp1 (2.5-fold) and Mrp3
(10-fold) was seen in livers of 2-AAF/PHx treated rats. In con-
trast with Mdr1b, this increase was not observed in
2- AAF/sham treated rats. In normal liver, both Mrp1 and
Mrp3 are expressed at low levels with Mrp3 localised only in
pericentral hepatocytes and cholangiocytes. In 2-AAF/PHx
treated rats, both Mrp1 and Mrp3 were predominantly
detected in HPCs. To further substantiate that Mrp1 and Mrp3
are indeed markers for HPCs, we determined the expression
profiles of ABC transporters in purified cell fractions enriched
in hepatocytes, cholangiocytes, or HPCs (Thy-1 positive cells).
In addition, we included the hepatic progenitor cell-like
RLF φ 13 cell line in these studies. Compared with hepatocytes,
freshly isolated Thy-1 positive cells showed high level expres-
sion of Mrp1 and Mrp3 and low expression of Mdr2, Bsep,Mrp2,
and Mrp6. Thus the ABC transporter phenotype of HPCs
resembles that of cholangiocytes, except for Mrp1 and Abca1,
which are highly expressed in progenitor cells but not in
cholangiocytes. The ABC transporter phenotype of RLF φ 13
cells resembles that of freshly isolated Thy-1 positive cells,
except for Mdr1b which is highly expressed in RLF φ 13 cells
only. However, high expression levels of Mdr1b are frequently
observed in cultured cells47 and cannot be regarded as a cell
type specific feature. Our functional assays using specific Mrp
inhibitors confirmed that RLF φ 13 cells are indeed able to
efficiently extrude Mrp specific substrates.
High expression levels of Mrp1 and Mrp3 observed in rat
HPCs is in agreement with the expression pattern seen in
severely diseased human liver in which we also observed high
level expression of MRP1 and MRP3 in regenerating ductules,
the site of progenitor cells (Ros et al, in press).
It has recently been shown that primitive haematopoietic
stem cells highly express Bcrp, the breast cancer resistance
protein.48 As HPCs display primitive features, we speculated
that these cells may also have high Bcrp expression. However,
in the 2-AAF/PHx model, Bcrp mRNA expression was not
induced. Neither RLF φ 13 nor Thy-1 positive cells were
particularly rich in Bcrp. Thus in contrast with haematopoietic
(side population) cells, Bcrp is not highly expressed in HPCs.
Taken together, these data demonstrate that HPCs have
high expression levels of functional Mrp1 and Mrp3. The cur-
rent view is that Mrp1 functions mainly as a cellular efflux
pump of cysteinyl-leukotrienes and glutathione-S-conjugates
andMrp3 as a pump for glucuronides and mono- and divalent
bile salts. Thus Mrp1 and Mrp3 may have a role in removing
both exogenous and endogenous toxic drugs/metabolites from
progenitor cells.
In conclusion, our findings show that strong induction of
Mdr1b in the 2-AAF/PHx model is confined to hepatocytes
while expression of Mrp1 and Mrp3 occurs mainly in HPCs.
HPCs appear to be well protected by these ABC transporters
which may enable them to survive in conditions associated
Figure 4 Fluorescence histogram. Representative fluorescence
histogram of RLF φ 13 cells showing carboxyfluorescein (CF) content
after 60 minutes of incubation with or without the specific Mrp
inhibitor MK571 (10 µM and 20 µM). Autofluorescence=control.
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Table 2 Expression of ATP binding
cassette transporter genes after 70%
partial hepatectomy (PHx)
Gene 24 h sham 24 h PHx
Mdr1a 1.00 (0.37) 1.29 (0.26)
Mdr1b 1.00 (0.25) 39.47 (1.09)*
Mdr2 1.00 (0.29) 2.08 (0.36)*
Bsep 1.00 (0.29) 0.89 (0.26)
Mrp1 1.00 (0.41) 1.90 (0.20)*
Mrp2 1.00 (0.41) 0.84 (0.08)
Mrp3 1.00 (0.27) 1.33 (0.39)
Mrp4 1.00 (0.13) 2.15 (0.35)*
Mrp6 1.00 (0.21) 0.66 (0.36)
Abca1 1.00 (0.40) 1.37 (0.23)
Bcrp 1.00 (0.65) 0.69 (0.13)
mRNA levels, as determined by real time
detection polymerase chain reaction analysis.
Values for sham operated animals were set to 1.
Values are means (SD) of four experiments.
*p<0.05.
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with excessive metabolic stress and serve as a proliferative
reservoir when the liver is severely damaged.
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